Improving Patient Prescription Access and Adherence Journeys

Today’s guest post comes from Bill Nolan, VP/GM of McKesson Specialty Health. Bill discusses ExpressCoverage™, a solution from McKesson and CoverMyMeds®. It offers new ways for McKesson’s Patient Support Services to electronically access and efficiently communicate with a vast network of physicians, payers, and pharmacies. Bill highlights how this tool improves the specialty patient’s access and adherence to therapy. To learn more, download the free document ExpressCoverage™: Revolutionizing Patient Drug Access For Pharmaceutical Companies. Read on for Bill’s insights. Read more » Copyright © 2006-2018 Pembroke Consulting, Inc. and Copyright © 2006-2018 Drug Channels. This Feed is for personal non-commercial … Continue reading Improving Patient Prescription Access and Adherence Journeys

Copay Accumulator Programs: TrialCard Measures the Impact on Patients and Pharmaceutical Manufacturers

Today’s guest post comes from Mark Bouck, President and CEO of TrialCard. Mark reviews copay accumulator adjustment programs and shares some of TrialCard’s unique data about these programs. He also discusses TrialCard’s proprietary methodology for identifying patients affected by this benefit design. This topic is crucial for 2018 (per my own article from January), so I encourage you to review his commentary. To learn more about TrialCard’s approach to copay accumulator programs, download the free e-book The Rise of Co-Pay Accumulator Programs: Are Your Brand’s Patients at Risk? To learn more about TrialCard’s solutions for accumulators, email Mark Droke, TrialCard’s Senior … Continue reading Copay Accumulator Programs: TrialCard Measures the Impact on Patients and Pharmaceutical Manufacturers

The Role of Specialty Pharmacy in Population Health and Value-Based Care

Today’s guest post comes from Russel Allinson, Chief Executive Officer at Therigy. Russel describes the current shift from volume-based to value-based contracting for enhanced population health and patient care. He explains Geisinger’s innovative and successful Medication Therapy Disease Management Program. Russel highlights how TherigySTM enables the transition from volume-based to value-based contracting. The system’s new features help specialty pharmacies better manage care delivery, tracking, and reporting to stakeholders, while maintaining focus on the bottom line. Read on for Russ’s insights. Read more » Copyright © 2006-2018 Pembroke Consulting, Inc. and Copyright © 2006-2018 Drug Channels. This Feed is for personal … Continue reading The Role of Specialty Pharmacy in Population Health and Value-Based Care

Triplefin: How An Independent Service Provider Is Positioning for Growth

Today’s guest post comes from Tom Doyle, Executive Vice President Commercial Solutions at H. D. Smith / Triplefin. Tom shares his views on how an ndependent patient services provider can enhance a manufacturer’s internal efficiency and the patient experience. He discusses patient assistance programs, automation, integration, and customer engagement. To learn more about Triplefin’s full range of solutions, visit their booth at next week’s CBI Trade and Channel Strategies conference or visit www.triplefin.com. Read more » Copyright © 2006-2017 Pembroke Consulting, Inc. and Copyright © 2006-2017 Drug Channels. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Triplefin: How An Independent Service Provider Is Positioning for Growth

Drug Spending in 2017: The CEO of Prime Therapeutics Responds to Drug Channels

A few weeks ago, I highlighted the latest drug spending data in Reality Check: New Prime Therapeutics Data Show Very Low Drug Spending Growth in 2017. As I see it, these data contradict the public rhetoric about excessive growth in drug spending and prices. I concluded that drug spending is not actually “out of control.” Jim DuCharme, president and CEO of Prime Therapeutics, emailed me with an alternative and much more critical interpretation of the drug spending situation. Fortunately, he didn’t seem to mind my artistic choices. Jim was kind enough to allow me to share his thoughts with the … Continue reading Drug Spending in 2017: The CEO of Prime Therapeutics Responds to Drug Channels

Insider Tips to Help Meet Patient Management Standards in URAC’s Specialty Pharmacy v3.0 Accreditation

Today’s guest post comes from Russel Allinson, co-founder, Chief Executive Officer, and Chief Clinical Officer of Therigy. Russ discusses the importance of understanding the latest URAC Specialty Pharmacy v3.0 accreditation requirements, particularly relating to patient management. To learn more, register for a free webinar co-hosted by Therigy and Cleveland Clinic. The webinar will be held on July 11, 2017, at 1:00 p.m. EDT. Read on for Russ’s insights. Read more » Copyright © 2006-2017 Pembroke Consulting, Inc. and Copyright © 2006-2017 Drug Channels. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Insider Tips to Help Meet Patient Management Standards in URAC’s Specialty Pharmacy v3.0 Accreditation